SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1AFF1809D3D78B8418C716A33E69F2DCBD9200A511AF69CBE3527A7D81593591004D3A2D7096C3683A59F16DA4B7E0A8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1AFF1809D3D78B8418C716A33E69F2DCBD9200A511AF69CBE3527A7D81593591004D3A2D7096C3683A59F16DA4B7E0A8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1AFF1809D3D78B8418C716A33E69F2DCBD9200A511AF69CBE3527A7D81593591004D3A2D7096C3683A59F16DA4B7E0A8
http://www.w3.org/2000/01/rdf-schema#comment
"we demonstrate that PVRIG and PVRL2 are expressed in human cancers and the PVRIG-PVRL2 and TIGIT-PVR pathways are nonredundant inhibitory signaling pathways."
xsd:string
http://purl.uniprot.org/uniprot/#_C450F997EAF6109B2102F04596A58E5E6CA7919C103DCECAA40FC608D09B17F753F9C5C5A56054BBB4C0C16A777375CA
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1AFF1809D3D78B8418C716A33E69F2DCBD9200A511AF69CBE3527A7D81593591004D3A2D7096C3683A59F16DA4B7E0A8
http://purl.uniprot.org/uniprot/Q7Z458
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1AFF1809D3D78B8418C716A33E69F2DCBD9200A511AF69CBE3527A7D81593591004D3A2D7096C3683A59F16DA4B7E0A8
http://purl.uniprot.org/uniprot/#_Q7Z458-mappedCitation-30659054
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1AFF1809D3D78B8418C716A33E69F2DCBD9200A511AF69CBE3527A7D81593591004D3A2D7096C3683A59F16DA4B7E0A8